Pharmaceutical Executive
November 18, 2009
Features
0
0
The business philosophy and tools that revolutionized Toyota could save the ailing drug industry a lot more than just time and money. But is pharma really capable of getting lean?
November 01, 2009
Features
0
0
Last year 90,000 pharma sales reps stopped in at hospitals and doctors' offices to woo doctors and dish out free samples. What would happen if they all went away? The answer is simple: everyone would be better off.
November 01, 2009
Washington Report
0
0
FDA and Congress weigh policies for improving drug safety via ads and written information.
November 01, 2009
Features
0
0
In today's "show me the money" marketplace, reimbursement strategy must innvolve more than seeking a good price based on ability to pay.
November 01, 2009
Columns
0
0
Executives should embrace design to discover new markets and find new ways to server customers.
November 01, 2009
Back Page
0
0
Emerging country markets are the new black in great expectations for pharma.
November 01, 2009
Column
0
0
The economy is turning around; leaders need to position their companies now for the market bounce.
November 01, 2009
Columns
0
0
Conversational marketing is a great resource for understanding and influencing physician–patient dialogues in the emerging healthcare environment.
November 01, 2009
From the Editor
0
0
Despite its success as a proponent of reform, the drug industry, whose main offering is a product easily siloed against other health services, remains vulnerable.
November 01, 2009
Features
0
0
Don't throw the sales force out with the bathwater. Accomplish more with fewer reps, less money and little effort. Impossible? Read on...